BHC (Bausch Health Companies Inc.) stock: $8.18, $3.06B market cap, $2.48B cash, $21.21B EV, $3.24B fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
The Company’s products are marketed directly or indirectly in approximately 90 countries. Our portfolio of products falls into five reportable segments: (i) Salix, (ii) International, (iii) Solta Medical, (iv) Diversified and (v) Bausch + Lomb. The following is a brief description of the Company’s segments: • The Salix segment consists of sales in the U.S. of GI products.
Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.
Partnerships DURECT Corporation (acquired Sep 2025; $84M total consideration + up to $350M sales-based milestones)
Indications
Severe alcohol-associated hepatitis (AH)(Phase 3)
Status note DURECT acquired Sep 2025 ($84M total consideration + up to $350M sales-based milestones); Breakthrough Therapy designation granted; registrational Phase 3 program in severe AH began Jan 2026.
Amiselimod
Phase 2 · Active
Target S1P
Indications
Ulcerative colitis (mild to moderate)(Phase 2)
Status note Phase 2 study in mild to moderate ulcerative colitis completed 2024; end-of-Phase-2 FDA meeting held 2024; EMA and PMDA feedback under review.
Status note Two global double-blind Phase 3 RED-C trials in early-stage liver cirrhosis failed to meet primary endpoints Jan 2026; company recognized ~$1.4B Salix goodwill impairment.
Per-asset detail extracted from the 10-Q filed 2026-07-30. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
Sponsor-matched active trials from ClinicalTrials.gov (27 as sponsor, 15 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.